← Back to headlines
Moderna Shares Slide as Investors Lock in Gains After Cancer Vaccine Rally
Moderna's stock shares declined as investors opted to secure profits after a recent surge driven by positive developments in its cancer vaccine research.
20 Aug, 10:01 — 20 Aug, 10:01
Sources
Showing 1 of 1 sources
